Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP861569.RAfHwNPqFwwDK19lzsnUdi71sKZ9QIZpqaV5GwAmk2SoI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP861569.RAfHwNPqFwwDK19lzsnUdi71sKZ9QIZpqaV5GwAmk2SoI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP861569.RAfHwNPqFwwDK19lzsnUdi71sKZ9QIZpqaV5GwAmk2SoI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP861569.RAfHwNPqFwwDK19lzsnUdi71sKZ9QIZpqaV5GwAmk2SoI130_provenance.
- NP861569.RAfHwNPqFwwDK19lzsnUdi71sKZ9QIZpqaV5GwAmk2SoI130_assertion description "[This study investigated the therapeutic potential of a BRAF(V600E)-selective inhibitor, PLX4032 (RG7204), for thyroid cancer by examining its effects on the MAP kinase signaling and proliferation of 10 thyroid cancer cell lines with wild-type BRAF or BRAF(T1799A) mutation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP861569.RAfHwNPqFwwDK19lzsnUdi71sKZ9QIZpqaV5GwAmk2SoI130_provenance.
- NP861569.RAfHwNPqFwwDK19lzsnUdi71sKZ9QIZpqaV5GwAmk2SoI130_assertion evidence source_evidence_literature NP861569.RAfHwNPqFwwDK19lzsnUdi71sKZ9QIZpqaV5GwAmk2SoI130_provenance.
- NP861569.RAfHwNPqFwwDK19lzsnUdi71sKZ9QIZpqaV5GwAmk2SoI130_assertion SIO_000772 21185263 NP861569.RAfHwNPqFwwDK19lzsnUdi71sKZ9QIZpqaV5GwAmk2SoI130_provenance.
- NP861569.RAfHwNPqFwwDK19lzsnUdi71sKZ9QIZpqaV5GwAmk2SoI130_assertion wasDerivedFrom befree-2016 NP861569.RAfHwNPqFwwDK19lzsnUdi71sKZ9QIZpqaV5GwAmk2SoI130_provenance.
- NP861569.RAfHwNPqFwwDK19lzsnUdi71sKZ9QIZpqaV5GwAmk2SoI130_assertion wasGeneratedBy ECO_0000203 NP861569.RAfHwNPqFwwDK19lzsnUdi71sKZ9QIZpqaV5GwAmk2SoI130_provenance.
- befree-2016 importedOn "2016-02-19" NP861569.RAfHwNPqFwwDK19lzsnUdi71sKZ9QIZpqaV5GwAmk2SoI130_provenance.